Cited by 26Autism Spectrum Disorder ResearchGenomics and Rare DiseasesGenomic variations and chromosomal abnormalities

Heterogeneity in clinical sequencing tests marketed for autism spectrum disorders

Open access
Hoang, Ny, Buchanan, Janet A., Scherer, Stephen W.·2018·npj Genomic Medicine

Abstract

Autism spectrum disorders (ASD) is now a high profile and common concern in the population. Diagnosis has long been based on clinical findings, 1 but with increased recognition of a strong genetic contribution and a subset of cases with an underlying genetic syndrome, 2 clinical laboratory testing to search for genomic risk variants is now an important component of the diagnostic work-up. Chromosomal microarray is currently the recommended first-tier genetic test for ASD, 3 revealing deleted and duplicated segments of DNA. These relatively large copy number variations (CNVs), often affecting several genes, can account for 5–25% of ASD cases, depending on the cohort examined. 4

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41525-018-0066-3

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Many clinical laboratories market next-generation sequencing test panels for ASD, and it has been asserted that there is a need to develop a validated list of genes appropriate for inclusion in ASD-specific clinical laboratory test panels.

    “Despite the lack of strong evidence of ASD specificity of large-effect rare variants, many clinical laboratories market next-generation sequencing test panels for ASD, and it has been asserted that there is a need to develop a validated list of genes appropriate for inclusion in ASD-specific clinical laboratory test panels.42”

    From Insufficient Evidence for “Autism-Specific” Genes (2020) · cites this paper as [42]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hoang, N., Buchanan, J. A., & Scherer, S. W.
Affiliations
  • University of Toronto (CA)
  • Hospital for Sick Children (CA)
Corresponding author
  • Hoang, Ny
  • Scherer, Stephen W.
Venue
npj Genomic Medicine
Published
2018-09-19
Volume
3
Issue
1
Pages
27-27
ISSN
2056-7944 (ISSN-L)
OpenAlex
W2890649749
Cited by
26
References
14
Citations by year
2026: 1 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 7 · 2020: 3 · 2019: 7
FWCI
2.53
Type
journal article
Language
en
Open access
Locations
  • npj Genomic Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • GlaxoSmithKline
  • Genome Canada
  • University of Toronto
  • Hospital for Sick Children
  • Canadian Institutes of Health Research
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
Keywords
autism spectrum disorder, genetic testing, copy number variation, chromosomal microarray analysis, genetic diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review